Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 234-808-1 | CAS number: 12034-57-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
In a bacterial reverse gene mutation assay the target substance niobium oxide was tested negative in S. typhimurium (TA 1535, TA 1537, TA 98 and TA 100) and E. coli (WP2uvrA). In addition, the source substance niobium pentachloride was tested negative in an in vitro HPRT test according to OECD 476 and in an in vitro Comet assay.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 2003-01-02 to 2003-03-20
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
- Specific details on test material used for the study:
- - Treatment of test material prior to testing: The test item was suspended in dimethylsulfoxide prior to use after crushing with a pestle and mortar to a fine dust, because there is no other suitable solvent. The suspension was carefully mixed immediately before administration. The homogeneity was proved visually.
- Target gene:
- Salmonella typhimurium TA1535, TA1537, TA 100, TA 98: Histidine locus
Escherichia coli WP2uvrA: Tryptophan locus - Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Details on mammalian cell type (if applicable):
- CELLS USED
- Source of cells: Prof. Bruce N. Ames (University of California, Berkely, USA)
MEDIA USED
- Nutrient medium: 15 g Nutrient broth (SIFIN GmbH, D-13088 Berlin) per litre
- Selective Agar: minimal glucose agar plates
- Overlay Agar: 9 g agar agar (Merck, D-64293 Darmstadt), 5 g NaCl, 100 mL sterile 0.5 mM Histidine/Biotine (Merck, D-64293 Darmstadt) solution per litre
- Species / strain / cell type:
- E. coli WP2 uvr A
- Details on mammalian cell type (if applicable):
- CELLS USED
- Source of cells: DSMZ (Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, 38124 Braunschweig, Germany)
MEDIA USED
- Nutrient medium: 15 g Nutrient broth (SIFIN GmbH, 13088 Berlin, Germany) per litre
- Selective Agar: minimal glucose agar plates
- Overlay Agar: 9 g agar agar (Merck, D-64293 Darmstadt), 5 g NaCl, 10 mL sterile Tryptophan solution (1 mg/ml; Merck, D-64293 Darmstadt) per litre.
- Metabolic activation:
- with and without
- Metabolic activation system:
- rat liver S9 mix
- Test concentrations with justification for top dose:
- TA 100 and the E. coli strain were tested in dose range finding study. A direct plate incorporation test was carried out, using concentrations of the test item of 5.0, 1.0, 0.5, 0.1, 0.05 and 0.01 mg/plate.
Based on the results the follwing five concentrations were chosen for the main experiment: 5.0, 1.0, 0.5, 0.1 and 0.05 mg/plate. - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Untreated negative controls:
- yes
- Remarks:
- untreated
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- Remarks:
- TA 100 and TA 1535 without S9, 5 µg/plate
- Untreated negative controls:
- yes
- Remarks:
- untreated
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- Remarks:
- TA 1537 without S9, 100 µg/plate
- Untreated negative controls:
- yes
- Remarks:
- untreated
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- Positive controls:
- yes
- Positive control substance:
- 2-nitrofluorene
- Remarks:
- TA 98 without S9, 5 µg/plate
- Untreated negative controls:
- yes
- Remarks:
- untreated
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- Positive controls:
- yes
- Positive control substance:
- methylmethanesulfonate
- Remarks:
- E.coli WP2uvrA, without S9, 1.3 µg/plate
- Untreated negative controls:
- yes
- Remarks:
- untreated
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- Positive controls:
- yes
- Positive control substance:
- other: 2-aminoanthracene
- Remarks:
- All strains, with S9, S. tymphimurium: 5.0 µg/plate, E.coli: 50.0 µg/plate
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation, Experiment I); pre-incubation (in suspension, Experiment II)
EXPERIMENTAL PERFORMANCE
- Experiment I:
The following were added to sterile tubes containing 2 ml of top agar: 0.1 ml of test item solution (or positive control or solvent) solution, 0.1 ml of bacteria culture, 0.5 ml of S9 mix (or 0.2 M phosphate buffer). The contents of each tube were mixed and added to a Petri dish containing minimal agar. Once the top agar had set, the dishes were inverted and incubated at 37 °C for 48 h.
- Experiment II:
The following were added to sterile tubes: 0.1 ml of test item solution (or positive control or solvent) solution, 0.1 ml of bacteria culture, 0.5 ml of S9 mix (or 0.2 M phosphate buffer). Each tube was fitted with a sterile cap and the contents were mixed followed by incubation at 37 °C for 20 min. Two ml of top agar were added to each tube and following mixing the contents were added to petri dishes containing minimal agar. When the top agar had set, the dishes were inverted and incubated at 37 °C for 48 h.
SCORING
Revertant colonies were scored manually at the end of the incubation period.
DURATION
- Pre-incubation period:(Experiment II): 20 min at 37 °C
- Exposure duration: 48 h at 37°C
NUMBER OF REPLICATIONS: 3
DETERMINATION OF CYTOTOXICITY
- Method: Plate incorporation test with S. typhimurium TA 100 and E. coli WP2 uvrA
- Determination of spontaneous revertants and condition of the bacterial background lawn - Evaluation criteria:
- - Positive Result:
A Test is considered to be positive if the test item induces dose related increases in numbers of revertants scored in two separate experiments and these
increases are deemed to be of biological relevance. Reproducible increases at one experimental point may also be indicative of a positive response. For a biologically relevant response the number of revertants is expected to be at least the double of spontaneous reversion.
- Negative Result:
A test item producing neither a dose related and reproducible increase in the number of revertants nor a reproducible positive response at any experiment point is considered to be non-mutagenic in this test system.
- Results of Positive Controls:
The positive controls should markedly increase the number of revertant colonies in all bacterial strains with and without metabolic activation to demonstrate the effective performance of each assay. - Statistics:
- The results are presented as individual plate counts. In addition mean values and standard deviations are calculated for each strain and experimental point. As unequivocal results were obtained in both experiments a statistical evaluation was not deemed to be necessary.
- Key result
- Species / strain:
- S. typhimurium, other: TA98, TA100, TA 1535 and TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- For detailed results please refer to Table 1 in box "Any other information on results incl. tables".
- Conclusions:
- In conclusion, the test item is not genotoxic in the bacterial reverse gene mutation assay in the presence and absence of mammalian metabolic activation.
- Executive summary:
In a reverse gene mutation assay in bacteria (EU method B.13/14), strains of S. typhimurium (TA 1535, TA 1537, TA 98 and TA 100) and E. coli strain (WP2uvrA) were exposed to Niobium(II) oxide (>99% purity) suspended in DMSO at concentrations of 5.0, 1.0, 0.5, 0.1 and 0.05 mg/plate in the presence and absence of mammalian metabolic activation. Niobium(II) oxide was tested up to the limit dose (5.0 mg/plate). The positive controls induced the appropriate responses in the corresponding strains. There was no evidence of induced mutant colonies over background.
This study is classified as acceptable and satisfies the requirement for Test Guideline Directive 67/548/EEC, Annex V, B.13/14 for in vitro mutagenicity (bacterial reverse gene mutation) data.
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Justification for type of information:
- For justification of read-across please refer to the read-across report attached to IUCLID section 13.
- Reason / purpose for cross-reference:
- read-across source
- Key result
- Species / strain:
- other: Human Jurkat T-lymphocytes
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- > 65% at 0.5 mM and higher in comparison to untreated controls
- Untreated negative controls validity:
- valid
- Positive controls validity:
- not examined
- Conclusions:
- Under the experimental conditions reported, the test item niobium chloride solution is considered to be non-mutagenic.
- Executive summary:
In an in vitro Comet assay, human Jurkat T-lymphocyte cells cultured in vitro were exposed to niobium chloride solution at concentrations of 0.05, 0.1, 0.5, 1.0 and 5 mM in the absence of mammalian metabolic activation.
For assessment of cytotoxicity apoptosis and cell viability were measured. Niobium chloride solution induced >50% caspase-9 positive cells at 0.5 mM concentration or higher (apoptosis) and a reduction of viable cells to <33% at 0.5 mM and higher (cell viability). Niobium chloride solution showed no effect on cell proliferation at the concentrations tested. No significant increase of DNA damage, measured by using an index of DNA damage (IDD, average tail length of 50 cells) were observed. Therefore, niobium chloride solution is considered to be not genotoxic in the Comet assay.
This information is used in a read-across approach in the assessment of the target substance.
For justification of read-across please refer to the attached read-across report (see IUCLID section 13).
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Justification for type of information:
- For justification of read-across please refer to the read-across report attached to IUCLID section 13.
- Reason / purpose for cross-reference:
- read-across source
- Key result
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- A biologically relevant growth inhibition (reduction of relative growth below 70%) was observed after the treatment with the test item in experiment I and II without metabolic activation
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: The pH-value detected with the test item was within the physiological range (pH 7.0 ± 0.4).
- Effects of osmolality: not examined
- Precipitation: Precipitation of the test item was noted in experiment I without metabolic activation at concentrations of 0.5 mM and higher and with metabolic activation at concentrations of 0.25 mM and higher. In experiment II precipitation was detected at concentrations of 0.2 mM and higher with metabolic activation.
RANGE-FINDING/SCREENING STUDIES:
A solubility test was performed with different solvents and vehicles. Based on the results of the solubility test EtOH was used as solvent. After pre-dissolving the test item in EtOH (100 mM) a dilution series was prepared in EtOH. First a 9fold volume of phosphate buffer was used adding it to each concentration. After noticing that in the pre-experiment without metabolic activation the buffer reacts with the cells the phosphate buffer was replaced for the main experiments by Aqua ad injectabilia. So the 9fold volume of Aqua ad injectabilia was added to each concentration. After an initial reaction of approx. 10 minutes, this test item solution was added to cell culture medium (MEM without serum) at a ratio of 1 :10, resulting in 1% EtOH and 9% Aqua ad injectabilia in the final treatment medium. The pH-value detected with the test item was within the physiological range (pH 7.0 ± 0.4). The solvent used is a composition of well-established solvents and is compatible with the survival of the cells and the activity of the S9 mix The toxicity of the test item was determined in pre-experiments. Eight concentrations [0.0025, 0.005, 0.01, 0.050, 0.10, 0.25, 0.50, 1.0 mM] were tested without and with metabolic activation. In the pre-experiment the test item concentrations were dissolved in 1% ethanol and 9% phosphate buffer. The experimental performance for the pre-experiment was the same as described below for the main experiments (excepting the solvent composition)
COMPARISON WITH HISTORICAL CONTROL DATA:
In all experiments the mutant values of the negative controls, the solvent controls and all mutant values of the test item concentrations found were within the historical control data of the test facility (without metabolic activation: 2-43 mutants per 10^6 cells, with metabolic activation: 5-44 mutants per 10^6 cells - Conclusions:
- Under the experimental conditions, the test item niobium pentachloride (decomposed) is considered to be non-mutagenic in the HPRT locus using V79 cells of the Chinese Hamster.
- Executive summary:
In a mammalian cell HPRT gene mutation assay, V79 cells cultured in vitro were exposed to niobium pentachloride (decomposed) (99.9 %) in 1% ethanol and 9% Aqua ad injectibilia at concentrations of 0.025, 0.05, 0.10, 0.25, 0.50, 0.75, 1.0, 1.5 and 2.0 mM in the presence and absence of mammalian metabolic activation (experiment I) and for experiment II at concentrations of 0.005, 0.010, 0.025, 0.050, 0.10, 0.25, 0.50, 0.75 and 1.0 mM without metabolic activation and 0.004, 0.007, 0.02, 0.04, 0.07, 0.2, 0.4, 0.7 and 1.0 mM with metabolic activation.
In experiment I and II with and without metabolic activation mutant values of the negative controls, the solvent controls and all mutant values of the test item concentrations found were within the historical control data.
For all tested treatment groups no dose-response relationship could be observed. The positive controls did induce the appropriate response. There was no evidence of induced mutant colonies over background.
This study is classified as acceptable. This study satisfies the requirement for Test Guideline OPPTS 870.5300, OECD 476 for in vitro mutagenicity (mammalian forward gene mutation) data.
This information is used in a read-across approach in the assessment of the target substance.
For justification of read-across please refer to the attached read-across report (see IUCLID section 13).
Referenceopen allclose all
Table 1: Summarized Results
Bacteria tester strain | Metabolic activation | Exp. | Mean numbers of revertants | Evaluation | |||||||
Controls | mg test item per plate | ||||||||||
UTC | VC | PC | 5.0 | 1.0 | 0.5 | 0.1 | 0.05 | ||||
Salmonella typhimurium | |||||||||||
TA1535 | no | 1st | 19.0 | 21.0 | 1269.3 | 18.3 | 19.0 | 19.0 | 20.7 | 19.0 | - |
no | 2nd | 18.0 | 18.3 | 1792.0 | 12.0 | 17.3 | 18.7 | 16.0 | 16.7 | - | |
yes | 1st | 25.0 | 27.0 | 282.7 | 22.3 | 22.0 | 22.7 | 21.3 | 24.3 | - | |
yes | 2nd | 18.7 | 21.0 | 309.3 | 21.0 | 19.0 | 21.7 | 19.7 | 19.7 | - | |
TA1537 | no | 1st | 8.7 | 11.7 | 2560.0 | 8.3 | 7.7 | 7.3 | 7.0 | 9.3 | - |
no | 2nd | 14.7 | 14.0 | 1600.0 | 13.3 | 13.0 | 12.7 | 11.0 | 10.7 | - | |
yes | 1st | 12.7 | 13.0 | 389.3 | 12.7 | 11.3 | 11.0 | 12.0 | 13.7 | - | |
yes | 2nd | 14.3 | 12.7 | 389.3 | 11.3 | 12.7 | 11.3 | 12.0 | 9.3 | - | |
TA 98 | no | 1st | 24.3 | 20.0 | 720.0 | 18.3 | 15.3 | 21.3 | 17.7 | 18.3 | - |
no | 2nd | 19.3 | 16.3 | 624.0 | 15.3 | 16.7 | 14.7 | 13.0 | 14.0 | - | |
yes | 1st | 25.7 | 24.7 | 3349.3 | 33.3 | 31.3 | 36.3 | 38.7 | 38.0 | - | |
yes | 2nd | 29.3 | 27.0 | 3109.3 | 30.7 | 30.3 | 27.3 | 30.3 | 31.7 | - | |
TA 100 | no | 1st | 201.3 | 20.0 | 1786.7 | 171.3 | 183.3 | 207.3 | 187.3 | 189.7 | - |
no | 2nd | 234.3 | 16.3 | 1445.3 | 189.7 | 188.0 | 183.0 | 190.0 | 206.0 | - | |
yes | 1st | 206.7 | 24.7 | 3642.7 | 198.7 | 168.0 | 204.0 | 195.3 | 190.0 | - | |
yes | 2nd | 221.0 | 27.0 | 3061.3 | 201.7 | 199.3 | 196.0 | 216.3 | 214.7 | - | |
Escherichia coli | |||||||||||
WP2uvrA | no | 1st | 27.3 | 23.3 | 282.7 | 282.7 | 26.7 | 26.3 | 25.7 | 23.7 | - |
no | 2nd | 27.7 | 28.0 | 378.7 | 378.7 | 29.0 | 28.7 | 32.7 | 29.0 | - | |
yes | 1st | 39.7 | 38.3 | 261.3 | 261.3 | 34.0 | 45.3 | 39.3 | 37.7 | - | |
yes | 2nd | 43.3 | 40.3 | 170.7 | 170.7 | 36.3 | 40.7 | 48.0 | 43.0 | - |
Abbreviations:
Exp.= independent experiment 1 or 2, 1stexperiment: plate incorporation method, 2ndexperiment: pre-incubation method
UTC = untreated control
VC = vehicle control
PC = positive control
- = none mutagenic effect
+ = mutagenic effect
TABLE 1: Concentrations of Metals Required to Induce a a Significant Harmful Effect (DNA Damage, Apoptosis, Viability, and Proliferation Inhibition) on T-Helper Jurkat Cells | |||||
Metal Concentrations (mM) |
DNA Damage |
Apoptosis | Viability | Proliferation Inhibition | Average Concentration of Four Parameters |
V | 0.05 | 0.05 | 1.0 | 0.05 | 0.29 |
Ni | 0.05 | 0.1 | 5.0 | 0.5 | 1.41 |
Co | 5.0 | 5.00 | 0.5 | 0.1 | 2.65 |
Cu | >5 | 0.5 | 5.0 | 0.1 | >2.65 |
Nb | >5 | 0.5 | 0.5 | >5 | >2.75 |
Mo | >5 | 1.0 | >5 | 0.5 | >2.87 |
Zr | 5.0 | 0.5 | 5.0 | >5 | >3.875 |
Be | >5 | 5.0 | 1.0 | 5.0 | >4 |
Cr | >5 | >5 | >5 | >5 | >5 |
Al | >5 | 5.0 | >5 | >5 | >5 |
Fe | >5 | 5.0 | >5 | >5 | >5 |
Significant effect: | |||||
DNA damage: IDD>75. | |||||
Apoptosis:>50% caspase 9-positive cells. | |||||
Viability: >50% PI-positive cells. | |||||
Proliferation inhibition: p<0.05 significance in metal-treated cells CPMs reduction compared to untreated controls. |
Table 1 | ||||||||||
Experiment I - Mutagenicity, without metabolic activation | ||||||||||
Dose Group | Concentration [mM] | Number of mutant colonies per flaska | Mean | SD | Mutant SD colonies per 106 cellsb |
Mutation factor | ||||
I | II | III | IV | V | ||||||
NC1 | 0 | 6 | 6 | 9 | 10 | 6 | 7.4 | 1.74 | 20.11 | |
NC2 | 4 | 6 | 6 | * | 8 | 6 | 1.41 | 18.29 | ||
S1 | 0 | 9 | 10 | 13 | 16 | 10 | 11 | 2.58 | 33.72 | |
S2 | 7 | 6 | 9 | 8 | 10 | 11.6 | 1.41 | 23.46 | ||
2 | 0.025 | 6 | 6 | 5 | 14 | 9 | 8 | 3.29 | 20.05 | 0.69 |
3 | 0.05 | 5 | 3 | 6 | 2 | 8 | 4.8 | 2.14 | 14.08 | 0.48 |
4 | 0.1 | 4 | 4 | 6 | 5 | 12 | 6.2 | 2.99 | 18.34 | 0.63 |
5 | 0.25 | 9 | 10 | 10 | 7 | 5 | 8.2 | 1.94 | 25.39 | 0.87 |
6 | 0.5 | 6 | 11 | 5 | 5 | 7 | 6.8 | 2.23 | 18.28 | 0.63 |
7 | 0.75 | 15 | 14 | 11 | 15 | 18 | 14.6 | 2.24 | 40.67 | 1.4 |
8 | 1.0 | 9 | 6 | 6 | 12 | 12 | 9 | 2.68 | 25.86 | 0.89 |
9 | 1.5 | 3 | 5 | 5 | 4 | 7 | 4.8 | 1.33 | 14.72 | 0.51 |
10 | 2.0 | 9 | 13 | 6 | 9 | 6 | 8.6 | 2.58 | 25.83 | 0.89 |
EMS | 300 µg/mL | 84 | 72 | 80 | 89 | 90 | 83 | 6.57 | 233.15 | 8.01 |
NC: | negative control/ medium control | |||||||||
S: | solvent control | |||||||||
a: | number of mutant colonies in flask I to V | |||||||||
b: | mean mutant colonies x 106/ (400000 x Cloning Efficiency/100) | |||||||||
EMS: | Ethylmethanesulfonate [300 µg/mL] | |||||||||
*: | Contamination of cell culture in flask |
Table 2 | ||||||||||
Experiment I - Mutagenicity, with metabolic activation | ||||||||||
Dose Group | Concentration [mM] | Number of mutant colonies per flaska | Mean | SD | Mutant SD colonies per 106 cellsb |
Mutation factor | ||||
I | II | III | IV | V | ||||||
NC1 | 0 | 5 | 5 | 6 | 6 | 11 | 6.6 | 2.24 | 20.06 | |
NC2 | 2 | 5 | 7 | 11 | 11 | 7.2 | 3.49 | 20.11 | ||
S1 | 0 | 3 | 5 | 6 | 7 | 10 | 6.2 | 2.32 | 18.62 | |
S2 | 3 | 4 | 9 | 9 | 10 | 7.0 | 2.90 | 19.83 | ||
2 | 0.025 | 4 | 4 | 5 | 6 | 10 | 5.8 | 2.23 | 14.61 | 0.76 |
3 | 0.05 | 5 | 12 | 8 | 3 | 8 | 7.2 | 3.06 | 18.56 | 0.97 |
4 | 0.10 | 11 | 10 | 11 | 10 | 11 | 10.6 | 0.49 | 30.64 | 1.59 |
5 | 0.25 | 5 | 6 | 7 | 10 | 14 | 8.4 | 3.26 | 20.64 | 1.07 |
6 | 0.50 | 2 | 2 | 4 | 5 | 5 | 3.6 | 1.36 | 9.65 | 0.50 |
7 | 0.75 | 3 | 7 | 8 | 9 | 9 | 7.2 | 2.23 | 19.15 | 1.00 |
8 | 1.0 | 4 | 8 | 11 | 12 | 12 | 9.4 | 3.07 | 25.61 | 1.33 |
9 | 1.5 | 7 | 7 | 8 | 8 | 9 | 7.8 | 0.75 | 18.22 | 0.95 |
10 | 2.0 | 7 | 7 | 9 | 9 | 11 | 8.6 | 1.50 | 22.34 | 1.16 |
DMBA | 0.8µg/mL | 105 | 107 | 133 | 96 | 97 | 107.6 | 13.41 | 303.95 | 15.81 |
DMBA | 1.0µg/mL | 111 | 149 | 118 | 122 | 109 | 121.8 | 14.39 | 369.09 | 19.20 |
NC: | negative control/ medium control | |||||||||
S: | solvent control | |||||||||
a: | number of mutant colonies in flask I to V | |||||||||
b: | mean mutant colonies x 106/ (400000 x Cloning Efficiency/100) | |||||||||
DMBA: | 7, 12-Dimethylbenz(a)anthracene [0.8 and 1.0 µg/mL] |
Table 3 | ||||||||||
Experiment II - Mutagenicity, without metabolic activation | ||||||||||
Dose Group | Concentration [mM] | Number of mutant colonies per flaska | Mean | SD | Mutant SD colonies per 106 cellsb |
Mutation factor | ||||
I | II | III | IV | V | ||||||
NC1 | 0 | 8 | 9 | 10 | 6 | 5 | 7.6 | 1.85 | 21.05 | |
NC2 | 14 | 8 | 5 | 9 | 12 | 9.6 | 3.14 | 26.89 | ||
S1 | 0 | 15 | 7 | 8 | 9 | 12 | 10.2 | 2.93 | 29.74 | |
S2 | 9 | 12 | 9 | 8 | 5 | 8.6 | 2.24 | 24.02 | ||
2 | 0.025 | 16 | 4 | 8 | 5 | 6 | 7.8 | 4.31 | 25.91 | 0.96 |
3 | 0.010 | 10 | 12 | 12 | 11 | 7 | 10.4 | 1.85 | 33.02 | 1.23 |
4 | 0.025 | 12 | 5 | 10 | 10 | 5 | 8.4 | 2.87 | 25.23 | 0.94 |
5 | 0.050 | 15 | 15 | 8 | 13 | 13 | 12.8 | 2.56 | 36.57 | 1.36 |
6 | 0.10 | 8 | 18 | 12 | 18 | 14 | 14.0 | 3.79 | 39.11 | 1.45 |
7 | 0.25 | 10 | 10 | 7 | 10 | 10 | 9.4 | 1.2 | 26.26 | 0.98 |
8 | 0.50 | 16 | 10 | 13 | 8 | 20 | 13.4 | 4.27 | 37.22 | 1.38 |
9 | 0.75 | 14 | 7 | 18 | 16 | 15 | 14.0 | 3.74 | 35.90 | 1.34 |
10 | 1.0 | 9 | 12 | 8 | 11 | 8 | 9.6 | 1.62 | 27.12 | 1.01 |
EMS | 300µg/mL | 160 | 175 | 179 | 169 | 177 | 172.0 | 6.87 | 607.77 | 22.61 |
NC: | negative control/ medium control | |||||||||
S: | solvent control | |||||||||
a: | number of mutant colonies in flask I to V | |||||||||
b: | mean mutant colonies x 106/ (400000 x Cloning Efficiency/100) | |||||||||
EMS: | Ethylmethanesulfonate [300 µg/mL] |
Table 4 | ||||||||||
Experiment II - Mutagenicity, with metabolic activation | ||||||||||
Dose Group | Concentration [mM] | Number of mutant colonies per flaska | Mean | SD | Mutant SD colonies per 106 cellsb |
Mutation factor | ||||
I | II | III | IV | V | ||||||
NC1 | 0 | 13 | 10 | 8 | 11 | 3 | 9.0 | 3.41 | 24.93 | |
NC2 | 19 | 12 | 18 | 12 | 16 | 15.4 | 2.94 | 43.38 | ||
S1 | 0 | 3 | 8 | 6 | 5 | 3 | 5.0 | 1.90 | 13.7 | |
S2 | 9 | 7 | 12 | 13 | 5 | 9.2 | 2.99 | 25.41 | ||
2 | 0.004 | 13 | 13 | 8 | 13 | 6 | 10.6 | 3.01 | 26.84 | 1.37 |
3 | 0.01 | 4 | 10 | 8 | 7 | 8 | 7.4 | 1.96 | 20.11 | 1.03 |
4 | 0.02 | 5 | 12 | 7 | 11 | 7 | 8.4 | 2.65 | 22.22 | 1.14 |
5 | 0.04 | 9 | 8 | 11 | 12 | 6 | 9.2 | 2.14 | 23.41 | 1.20 |
6 | 0.07 | 15 | 6 | 10 | 12 | 7 | 10.0 | 3.29 | 25.71 | 1.31 |
7 | 0.2 | 7 | 8 | 4 | 11 | 14 | 8.8 | 3.43 | 26.19 | 1.34 |
8 | 0.4 | 9 | 13 | 14 | 17 | 13 | 13.2 | 2.56 | 35.97 | 1.84 |
9 | 0.7 | 9 | 13 | 12 | 9 | 6 | 9.8 | 2.48 | 29.17 | 1.49 |
10 | 1.0 | 13 | 10 | 14 | 12 | 13 | 12.4 | 1.36 | 35.63 | 1.82 |
DMBA | 0.8µg/mL | 77 | 89 | 71 | 88 | 90 | 83.0 | 7.62 | 244.12 | 12.48 |
DMBA | 1.0µg/mL | 109 | 120 | 126 | 106 | 114 | 115.0 | 7.27 | 357.14 | 18.26 |
NC: | negative control/ medium control | |||||||||
S: | solvent control | |||||||||
a: | number of mutant colonies in flask I to V | |||||||||
b: | mean mutant colonies x 106/ (400000 x Cloning Efficiency/100) | |||||||||
DMBA: | 7, 12-Dimethylbenz(a)anthracene [0.8 and 1.0 µg/mL] |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Genotoxicity of the target substance was assessed in several in vitro genotoxicity tests. The target substance niobium oxide was not genotoxic in a bacterial reverse gene mutation assay (Ames test). As no further data is available for the target substance, data from the source substance niobium pentachloride was used. For details and justification of the read-across approach please refer to the report attached in IUCLID section 13. The source substance niobium pentachloride was tested negative in an in vitro HPRT test conducted according to OECD 476 and furthermore in an in vitro Comet assay.
Justification for classification or non-classification
Based on the available data, the target substance does not warrant classification for mutagenicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.